Chronic graft-versus-host disease suppressing CD56Perforin regulatory-like NK cells inhibit CD4 T cells via PD-1, LAG-3, and TRAIL.
TL;DR
NKreg-like cells were found to secrete several regulatory proteins, including IL-10, TGF-β, adenosine, and TRAIL, and extracellular vesicles enriched in EOMES, and NKreg-like cells were found to selectively suppress CD4+ T cells with no impact on B cells, NK cells, or Treg cells, mediated by the PD-1, LAG-3, and TRAIL pathways.
OpenAlex 토픽 ·
Immune Cell Function and Interaction
Cancer Immunotherapy and Biomarkers
CAR-T cell therapy research
NKreg-like cells were found to secrete several regulatory proteins, including IL-10, TGF-β, adenosine, and TRAIL, and extracellular vesicles enriched in EOMES, and NKreg-like cells were found to selec
- 표본수 (n) 3
APA
Madeline P. Lauener, Marie-Hélène Normand, et al. (2026). Chronic graft-versus-host disease suppressing CD56Perforin regulatory-like NK cells inhibit CD4 T cells via PD-1, LAG-3, and TRAIL.. Cytotherapy, 28(5), 102062. https://doi.org/10.1016/j.jcyt.2026.102062
MLA
Madeline P. Lauener, et al.. "Chronic graft-versus-host disease suppressing CD56Perforin regulatory-like NK cells inhibit CD4 T cells via PD-1, LAG-3, and TRAIL.." Cytotherapy, vol. 28, no. 5, 2026, pp. 102062.
PMID
41762961
Abstract
[BACKGROUND] Chronic graft-versus-host disease (cGvHD) is a significant cause of morbidity and mortality after hematopoietic stem cell transplantation (HSCT). Previously, in large human cohorts of HSCT patients we identified increased numbers of CD56Perforin NK cells ([regulatory-like NK cells] [NK-like]) to associate with cGvHD suppression. Our further studies demonstrated that NK-like cells can be characterized according to a unique phenotype and transcriptome, distinct from classic cytolytic NK cells, and can induce immune tolerance by selectively suppressing CD4 T cells through a non-cytolytic, contact-dependent mechanism. Further, we demonstrated that the NK-like cells can be expanded up to 300-fold while maintaining their regulatory phenotype, function, and transcriptomic characteristics.
[OBJECTIVE(S)] We aimed to further elucidate the mechanism of human NK-like cells towards inflammatory immune cells to better understand their immunoregulatory function while also determining the frequency of such cells in human blood.
[STUDY DESIGN] CD56CD16 NK-like cells were sterile sorted from healthy human donors, and co-cultured with cell proliferation dye stained and activated CD4 T cells, T cells ± dendritic cells, B cells, or NK cells for 96 hours to measure responder cell proliferation in the presence of NK-like cells (N = 3-5). For proteomics analysis, supernatant from 24 hr or 20-day cultured/expanded NK-like cells and classic cytolytic NK cells (CD56CD16 NK cells) were collected and sent to Olink Proteomics for analysis (N=6). For extracellular vesicle analysis, supernatant from NK-like cells expanded for 20 days underwent differential ultracentrifugation, small particle flow cytometry analysis, and nanoLC-MS/MS proteomics analysis. Lastly, NK-like cell frequency was measured via FACS cell sorting analysis according to sex and age demographics (N=20). Statistical analyses were performed using Microsoft Excel version 2110 and a 2-tailed T test - 2-sample assuming unequal variance, or the Welch 2 Sample t-test.
[RESULTS] NK-like cells were found to secrete several regulatory proteins, including IL-10, TGF-β, adenosine, and TRAIL, and extracellular vesicles enriched in EOMES. Further, NK-like cells were found to selectively suppress CD4 T cells with no impact on B cells, NK cells, or T cells, mediated by the PD-1, LAG-3, and TRAIL pathways. Finally, we determined no significant difference in NK-like cell frequency according to age or sex demographics.
[CONCLUSION(S)] The results of these studies contribute to our understanding of how NK-like cells induce a selective suppressive function to promote tolerance. Further, this data provides applications for enhancing NK-like cell function, such as through increasing PD-1, LAG-3, TRAILR ligand, and/or EOMES expression/secretion, and the ability to obtain consistent cell numbers from donors, regardless of age and sex.
[OBJECTIVE(S)] We aimed to further elucidate the mechanism of human NK-like cells towards inflammatory immune cells to better understand their immunoregulatory function while also determining the frequency of such cells in human blood.
[STUDY DESIGN] CD56CD16 NK-like cells were sterile sorted from healthy human donors, and co-cultured with cell proliferation dye stained and activated CD4 T cells, T cells ± dendritic cells, B cells, or NK cells for 96 hours to measure responder cell proliferation in the presence of NK-like cells (N = 3-5). For proteomics analysis, supernatant from 24 hr or 20-day cultured/expanded NK-like cells and classic cytolytic NK cells (CD56CD16 NK cells) were collected and sent to Olink Proteomics for analysis (N=6). For extracellular vesicle analysis, supernatant from NK-like cells expanded for 20 days underwent differential ultracentrifugation, small particle flow cytometry analysis, and nanoLC-MS/MS proteomics analysis. Lastly, NK-like cell frequency was measured via FACS cell sorting analysis according to sex and age demographics (N=20). Statistical analyses were performed using Microsoft Excel version 2110 and a 2-tailed T test - 2-sample assuming unequal variance, or the Welch 2 Sample t-test.
[RESULTS] NK-like cells were found to secrete several regulatory proteins, including IL-10, TGF-β, adenosine, and TRAIL, and extracellular vesicles enriched in EOMES. Further, NK-like cells were found to selectively suppress CD4 T cells with no impact on B cells, NK cells, or T cells, mediated by the PD-1, LAG-3, and TRAIL pathways. Finally, we determined no significant difference in NK-like cell frequency according to age or sex demographics.
[CONCLUSION(S)] The results of these studies contribute to our understanding of how NK-like cells induce a selective suppressive function to promote tolerance. Further, this data provides applications for enhancing NK-like cell function, such as through increasing PD-1, LAG-3, TRAILR ligand, and/or EOMES expression/secretion, and the ability to obtain consistent cell numbers from donors, regardless of age and sex.
MeSH Terms
Humans; Graft vs Host Disease; Killer Cells, Natural; CD4-Positive T-Lymphocytes; CD56 Antigen; Programmed Cell Death 1 Receptor; TNF-Related Apoptosis-Inducing Ligand; Male; Female; Antigens, CD; Chronic Disease; Adult; Hematopoietic Stem Cell Transplantation; Middle Aged